重新评估COVID-19和1型糖尿病之间的关系:方法论上的考虑
Er-Min Liang1, Hong-Cheng Luo2,3
1Department of Respiratory Medicine, Anting Hospital of Jiading District, Shanghai 201805, China.
World journal of diabetes
|November 24, 2025
概括
新冠肺炎2019 (COVID-19) 疫情可能改变了1型糖尿病 (T1DM) 发病率和季节性. 之前一项研究的方法限制表明,对与流行病相关的T1DM增加进行谨慎的解释.
科学领域:
- 流行病学 流行病学
- 免疫学 免疫学 免疫学
- 公共卫生 公共卫生
背景情况:
- 一项全国性的队列研究表明,在2019年冠状病毒病 (COVID-19) 流行期间,1型糖尿病 (T1DM) 发病率增加和季节性变化.
- 该研究指出,新发型T1DM病例较高,冬季峰值较低,与呼吸道病毒循环减少相关.
- 假设T1DM与包括SARS-CoV-2在内的病毒感染之间的潜在联系.
研究的目的:
- 批判性地评估最近一项关于COVID-19大流行期间T1DM发病率的研究的方法限制.
- 讨论影响有关T1DM和病毒感染发现的解释的潜在偏见.
- 强调需要谨慎解释,并为未来的研究提出改进建议.
主要方法:
- 对研究设计和来自Carmon等人的数据的审查.
- 潜在偏差的讨论:生态推断,混因素,诊断延迟,缺乏COVID-19分层,以及病毒监测数据偏差.
- 论点的支持与最近的科学文献.
主要成果:
- 由于缺乏个体级数据,观察到T1DM发病率与病毒循环之间的关联容易产生生态谬论.
- 无法控制的混因素 (例如,医疗保健准入,社会经济因素) 和未能按COVID-19状态分层限制因果推断.
- 流行病相关的诊断延迟可能导致明显T1DM发病率膨胀,由糖尿病酸性脂肪酸症的增加率表明;病毒监测数据也显示了偏差.
结论:
- 疫情对T1DM发病率的影响值得关注,但由于现有研究的方法限制,需要仔细解释.
- 未来的研究应该优先考虑个人层面的分析,对混因素的控制,将发病率变化与诊断延迟区分开来,并按感染状况分层.
- 强有力的结论需要全面的病毒暴露数据和严格的研究设计,以准确评估感染和T1DM之间的关系.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Diabetes: Symptoms, Diagnosis, and Complications
2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Psychoneuroimmunology: Diabetes and Cancer
417
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
417
Diabetes: Management and Pharmacotherapy
851
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
851


